Table 2.
Literature overview of papers reporting on endoprosthetic acetabular reconstruction techniques after tumour resection.
| Author | Number of patients | Follow-up (months) | Type of implant | Pelvic ring restoration | Bloodloss (ml) | Surgical time (hours) | Clear margins | Dislocation | Aseptic loosening | Structural failure | Infection | Local recurrence | Implant survival | MSTS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pelvic tumour implants non custom or modular | ||||||||||||||
| Bus et al. 33 | 19 | 39 | Pedestal zimmer | No | na | na | na | 26% | 15% | 21% | 47% | 21% | 50% | 49% |
| Bus et al. 6 | 47 | 47 | LUMiC implantcast | No | 2300 | 6.5 | 87% | 21% | 1% | 6% | 30% | 11% | 82% | 70% |
| Ji et al. 34 | 100 | 53 | Modular | na | 2700 | na | 91% | 9% | 2% | 5% | 15% | 20% | 64% | 57% |
| Wang et al. 35 | 50 | 54 | Modular | Yes | 4200 | 6.8 | 82% | 4% | 2% | 10% | 14% | 18% | 64% | 61% |
| Menendez et al. 36 | 24 | 29 | Modular | No | na | na | na | 12% | na | 8% | 32% | 20% | 84% | 67% |
| Guo et al. 9 | 28 | 30 | 3D printed modular | Yes | 4800 | 5.4 | 96% | 4% | 0% | 7% | 14% | 25% | 93% | 62% |
| Liang et al. 12 | 35 | 21 | 3D printed modular | No | 2206 | 4.3 | 83% | 6% | 0% | 0% | 0%% | 14% | 100% | 64% |
| Pelvic tumour implants custom. old generation | ||||||||||||||
| Witte et al. 37 | 40 | 24 | Mutars | No | na | na | 98% | 3% | 8% | 15% | 30% | 18% | 61% | 50% |
| Jaiswal et al. 14 | 98 | 65 | Stanmore | No | na | na | na | 20% | 24% | 3% | 30% | 31% | 68% | 59% |
| Abudu et al. 15 | 35 | 84 | Stanmore | No | na | na | na | 17% | 3% | 6% | 26% | 23% | na | 70% |
| Müller et al. 38 | 9 | 62 | Howmedica | Yes | na | na | na | 11% | 22% | na | 56% | 0% | 67% | na |
| Ozaki et al. 16 | 12 | 57 | Howmedica | Yes | na | na | 92% | 8% | 8% | 33% | 25% | 50% | 58% | 37% |
| Tunn et al. 39 | 24 | 98 | Mutars | Yes/No | 2300 | 8.8 | 96% | 4% | 17% | na | 42% | 21% | 33% | na |
| Dai et al. 40 | 10 | 34 | Custom | Yes | na | na | na | 20% | 0% | 10% | 30% | 34% | 100% | na |
| Pelvic tumour implants custom. new generation | ||||||||||||||
| Wang et al. 13 | 13 | 27 | Chunli Co | Yes | 2600 | 4.3 | na | 0% | 0% | 0% | 15% | 0% | 100% | 77% |
| Peng et al. 17 | 6 (5 oncology) | 30 | Custom | Yes | 2500 | 4.1 | na | 0% | 0% | 0% | 0% | 0% | 100% | 66% |
| Angelini et al. 18 | 41 (22 oncology) | 60 | Multiple manufacturers | na | 1200 | 4.5 | 76% | 0% | 0% | 0% | 9% | 0% | 100% | 70% |
| This study | 15 | 34 | OSSIS | Yes | 5000 | 5.5 | 92% | 7% | 0% | 20% | 7% | 7% | 73% | 63% |